➤ Get the DrugPatentWatch Daily Briefing


Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

Claims for Patent: 8,921,341

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,921,341
Title:Antiviral compounds
Assignee: Gilead Pharmasset LLC (Foster City, CA)
Application Number:14/049,133
Patent Claims: 1. A compound of the formula: ##STR00184##

2. A pharmaceutical composition comprising a compound of the formula: ##STR00185## and a pharmaceutically acceptable carrier.

3. The pharmaceutical composition of claim 2, further comprising an inhibitor of hepatitis C virus NS5B polymerase.

4. A method of treating hepatitis C virus in a human patient in need thereof, said method comprising administering to the human patient a pharmaceutical composition comprising a therapeutically effective amount of the compound of the formula: ##STR00186##

5. The method of claim 4, further comprising administering an inhibitor of hepatitis C virus NS5B polymerase.

6. The method of claim 5, further comprising administering an interferon or pegylated interferon to the patient.

7. The method of claim 5, further comprising administering ribavirin to the patient.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
